Neutrophils confer T cell resistance to myeloid-derived suppressor cell-mediated suppression to promote chronic inflammation

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 5037-5047

  Ryan, Sean O ^a   Johnson, Jenny L ^a   Cobb, Brian A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOMODULATION; INNATE IMMUNITY; LEUKOCYTE FUNCTION; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUPPRESSOR CELL;

AGING; ANIMALS; ANTIGENS, CD11B; BACTEROIDES FRAGILIS; BIOLOGICAL MARKERS; CELL CYCLE; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NADPH OXIDASE; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 84877800844     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203404     Document Type: Article

References (57)

1. Heron, M. 2012. Deaths: leading causes for 2008. Natl. Vital Stat. Rep. 60: 1-94.
2. Licastro, F., G. Candore, D. Lio, E. Porcellini, G. Colonna-Romano, C. Franceschi, and C. Caruso. 2005. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun. Ageing 2: 8-22.
3. Candore, G., C. Caruso, E. Jirillo, T. Magrone, and S. Vasto. 2010. Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-Ageing strategies and successful ageing achievement. Curr. Pharm. Des. 16: 584-596.
4. IL6R Genetics Consortium Emerging Risk Factors Collaboration. 2012. Interleukin-6 receptor pathways in coronary heart disease: a collaborative metaanalysis of 82 studies. Lancet 379: 1205-1213.
5. Brusselle, G. G., G. F. Joos, and K. R. Bracke. 2011. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378: 1015-1026.
6. Henckaerts, L., C. Figueroa, S. Vermeire, and M. Sans. 2008. The role of genetics in inflammatory bowel disease. Curr. Drug Targets 9: 361-368. (Pubitemid 352025209)
7. Németh, T., and A. Mócsai. 2012. The role of neutrophils in autoimmune diseases. Immunol. Lett. 143: 9-19.
8. Muller, I., M. Munder, P. Kropf, and G. M. Hansch. 2009. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol. 30: 522-530.
9. Facciabene, A., G. T. Motz, and G. Coukos. 2012. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 72: 2162-2171.
10. Ostrand-Rosenberg, S., P. Sinha, D. W. Beury, and V. K. Clements. 2012. Crosstalk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin. Cancer Biol. 22: 275-281.
11. Greten, T. F., M. P. Manns, and F. Korangy. 2011. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 11: 802-807.
12. Haile, L. A., R. von Wasielewski, J. Gamrekelashvili, C. Kruger, O. Bachmann, A. M. Westendorf, J. Buer, R. Liblau, M. P. Manns, F. Korangy, and T. F. Greten. 2008. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135: 871-881, 881, e1-e5.
13. + TH1-like responses. J. Clin. Invest. 98: 1010-1020. (Pubitemid 26293320)
14. Yin, Z., G. Bahtiyar, N. Zhang, L. Liu, P. Zhu, M. E. Robert, J. McNiff, M. P. Madaio, and J. Craft. 2002. IL-10 regulates murine lupus. J. Immunol. 169: 2148-2155. (Pubitemid 34857682)
15. Hata, H., N. Sakaguchi, H. Yoshitomi, Y. Iwakura, K. Sekikawa, Y. Azuma, C. Kanai, E. Moriizumi, T. Nomura, T. Nakamura, and S. Sakaguchi. 2004. Distinct contribution of IL-6, TNF-A, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J. Clin. Invest. 114: 582-588. (Pubitemid 39572108)
16. Lio, D., F. Licastro, L. Scola, M. Chiappelli, L. M. Grimaldi, A. Crivello, G. Colonna-Romano, G. Candore, C. Franceschi, and C. Caruso. 2003. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun. 4: 234-238. (Pubitemid 38967602)
17. Paul, G., V. Khare, and C. Gasche. 2012. Inflamed gut mucosa: downstream of interleukin-10. Eur. J. Clin. Invest. 42: 95-109.
18. Caruso, C., D. Lio, L. Cavallone, and C. Franceschi. 2004. Aging, longevity, inflammation, and cancer. Ann. N. Y. Acad. Sci. 1028: 1-13. (Pubitemid 40361805)
19. Lio, D., L. Scola, A. Crivello, G. Colonna-Romano, G. Candore, M. Bonafe, L. Cavallone, C. Franceschi, and C. Caruso. 2002. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun. 3: 30-33. (Pubitemid 38961103)
20. Gallin, J. I., and E. S. Buescher. 1983. Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease. Inflammation 7: 227-232. (Pubitemid 14155225)
21. Gelderman, K. A., M. Hultqvist, A. Pizzolla, M. Zhao, K. S. Nandakumar, R. Mattsson, and R. Holmdahl. 2007. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J. Clin. Invest. 117: 3020-3028. (Pubitemid 47529631)
22. Lambeth, J. D. 2007. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic. Biol. Med. 43: 332-347. (Pubitemid 46992767)
23. Rosenzweig, S. D. 2008. Inflammatory manifestations in chronic granulomatous disease (CGD). J. Clin. Immunol. 28(Suppl. 1): S67-S72.
24. Holland, S. M. 2010. Chronic granulomatous disease. Clin. Rev. Allergy Immunol. 38: 3-10.
25. Marks, D. J. B., K. Miyagi, F. Z. Rahman, M. Novelli, S. L. Bloom, and A. W. Segal. 2009. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am. J. Gastroenterol. 104: 117-124.
26. Roesler, J., A. Koch, G. Porksen, H. von Bernuth, S. Brenner, G. Hahn, R. Fischer, N. Lorenz, M. Gahr, and A. Rosen-Wolff. 2005. Benefit assessment of preventive medical check-ups in patients suffering from chronic granulomatous disease (CGD). J. Eval. Clin. Pract. 11: 513-521. (Pubitemid 41789733)
27. Cobb, B. A., Q. Wang, A. O. Tzianabos, and D. L. Kasper. 2004. Polysaccharide processing and presentation by the MHCII pathway. Cell 117: 677-687. (Pubitemid 38692532)
28. Pollock, J. D., D. A. Williams, M. A. Gifford, L. L. Li, X. Du, J. Fisherman, S. H. Orkin, C. M. Doerschuk, and M. C. Dinauer. 1995. Mouse model of Xlinked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9: 202-209.
29. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274. (Pubitemid 23320290)
30. Lewis, C. J., and B. A. Cobb. 2011. Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide production. Eur. J. Immunol. 41: 2562-2572.
31. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83: 64-70.
32. Hu, X., and L. B. Ivashkiv. 2009. Cross-regulation of signaling pathways by interferon-g: implications for immune responses and autoimmune diseases. Immunity 31: 539-550.
33. Tzianabos, A. O., and D. L. Kasper. 2002. Role of T cells in abscess formation. Curr. Opin. Microbiol. 5: 92-96. (Pubitemid 34118164)
34. Koguchi, K., D. E. Anderson, L. Yang, K. C. O'Connor, V. K. Kuchroo, and D. A. Hafler. 2006. Dysregulated T cell expression of TIM3 in multiple sclerosis. J. Exp. Med. 203: 1413-1418. (Pubitemid 43877603)
35. + signaling in synovial fluid T lymphocytes from patients with chronic inflammatory arthritis. Arthritis Rheum. 43: 1257-1265. (Pubitemid 30416310)
36. Yamazaki, M., T. Yajima, M. Tanabe, K. Fukui, E. Okada, R. Okamoto, S. Oshima, T. Nakamura, T. Kanai, M. Uehira, et al. 2003. Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis. J. Immunol. 171: 1556-1563. (Pubitemid 36900091)
37. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
38. Mazzoni, A., V. Bronte, A. Visintin, J. H. Spitzer, E. Apolloni, P. Serafini, P. Zanovello, and D. M. Segal. 2002. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168: 689-695. (Pubitemid 34049569)
39. Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499-4506.
40. Garvey, E. P., J. A. Oplinger, E. S. Furfine, R. J. Kiff, F. Laszlo, B. J. R. Whittle, and R. G. Knowles. 1997. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272: 4959-4963. (Pubitemid 27090046)
41. Lewis, C. J., and B. A. Cobb. 2010. Carbohydrate oxidation acidifies endosomes, regulating antigen processing and TLR9 signaling. J. Immunol. 184: 3789-3800.
42. + T cells. J. Clin. Invest. 116: 2777-2790. (Pubitemid 44511641)
43. Niedbala,W., J. C. Alves-Filho, S. Y. Fukada, S. M. Vieira, A. Mitani, F. Sonego, A. Mirchandani, D. C. Nascimento, F. Q. Cunha, and F. Y. Liew. 2011. Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proc. Natl. Acad. Sci. USA 108: 9220-9225.
44. Johnson, S. R., and J. T. Granton. 2011. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. Eur. Respir. Rev. 20: 277-286.
45. Barnes, P. J. 2011. Pathophysiology of allergic inflammation. Immunol. Rev. 242: 31-50.
46. Ridker, P. M., T. Thuren, A. Zalewski, and P. Libby. 2011. Interleukin-1b inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am. Heart J. 162: 597-605.
47. Ridker, P. M. 2009. Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). J. Thromb. Haemost. 7(Suppl. 1): 332-339.
48. Ash, Z., and P. Emery. 2012. The role of tocilizumab in the management of rheumatoid arthritis. Expert Opin. Biol. Ther. 12: 1277-1289.
49. Deffert, C., S. Carnesecchi, H. Yuan, A. L. Rougemont, T. Kelkka, R. Holmdahl, K. H. Krause, and M. G. Schappi. 2012. Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells. J. Pathol. 228: 341-350.
50. Antignano, F., M. Hamilton, S. Patterson, V. Ho, C. Cohen, M. K. Levings, and G. Krystal. 2011. SHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanism. PLoS One 6: e21893.
51. Amulic, B., C. Cazalet, G. L. Hayes, K. D. Metzler, and A. Zychlinsky. 2012. Neutrophil function: frommechanisms to disease.Annu. Rev. Immunol. 30: 459-489.
52. Thewissen, M., J. Damoiseaux, J. van de Gaar, and J. W. C. Tervaert. 2011. Neutrophils and T cells: bidirectional effects and functional interferences. Mol. Immunol. 48: 2094-2101.
53. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6: 173-182. (Pubitemid 43290987)
54. Yin, J., and T. A. Ferguson. 2009. Identification of an IFN-g-producing neutrophil early in the response to Listeria monocytogenes. J. Immunol. 182: 7069-7073.
55. Ellis, T. N., and B. L. Beaman. 2002. Murine polymorphonuclear neutrophils produce interferon-g in response to pulmonary infection with Nocardia asteroides. J. Leukoc. Biol. 72: 373-381.
56. Yamada, M., J. C. Gomez, P. E. Chugh, C. A. Lowell, M. C. Dinauer, D. P. Dittmer, and C. M. Doerschuk. 2011. Interferon-g production by neutrophils during bacterial pneumonia in mice. Am. J. Respir. Crit. Care Med. 183: 1391-1401.
57. Klebanoff, S. J., S. Olszowski, W. C. Van Voorhis, J. A. Ledbetter, A. M. Waltersdorph, and K. G. Schlechte. 1992. Effects of gamma-interferon on human neutrophils: protection from deterioration on storage. Blood 80: 225-234.